Medicine
STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is resurrecting its lead program:
STAT+: Pharmalittle: We’re reading about a Novo setback in court, a House probe into big PBMs, and more
A U.S. judge rejected a bid to block Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign about weight loss drugs
A possible treatment for brain-eating amoebas, found in the sea
Brain-eating amoebas are hard to treat and nearly always fatal. But researchers have isolated a compound that could help stop the disease.
I struggled to come to terms with my mum’s death. Then I swam in the sea and suddenly felt connected to her
My mother was a keen swimmer, and she lived with depression. I wonder if she found the same respite in the water that has helped heal me since she passed awayIt was early morning …
Women: was your autoimmune condition misdiagnosed?
We want to hear from women with autoimmune conditions who received an incorrect or delayed diagnosisHundreds of millions of people – roughly one in ten globally – are affected by …
STAT+: Pennsylvania Dutch country, tired of waiting for biopharma, builds drug company of its own
A small community tests if it can solve a crisis no one else could, for the simple reason that they have no other choice.
Opinion: Cancer vaccines are finally here. How do we get them to patients?
“If we want cancer vaccines to reach patients faster than BRCA testing did, there are several challenges to address now,” write Karen E. Knudsen and Othman Laraki.
Opinion: Emergency pediatric care is now in permanent crisis mode
“In 2026, the unprecedented pediatric patient crowding of 2022 has become a normal Tuesday,” write Jonathan Kohler and Mary King.
Perimenopause is everywhere. How do you know if you’re in it? – podcast
Perimenopause has become a hot topic, with celebrities sharing their experiences and doctors offering tips and advice online. But despite the benefits of growing awareness, a risi…
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
STAT+: Nonprofit Bon Secours Mercy Health strikes $5.7 billion deal for surgery center chain
The deal would make the Catholic system one of the largest operators of outpatient surgery centers.
STAT+: HHS relaxes security, transparency rules for health record software used by hospitals
The Trump administration removed several security, privacy and transparency requirements for vendors of EHR software.
Bigger does not always mean better in hospital care | Letter
For some medics, working at a large centre means for the same pay you don’t have to work so hard, writes Dr Paul GodwinThe closure of maternity units is always a temptation when t…
STAT+: House lawmaker probes PBMs for ‘punitive’ audits of independent pharmacies
A House lawmaker is investigating whether the three largest PMS targeted independent pharmacies withretaliatory audits.
STAT+: GSK sees its return to cancer starting to pay off
A decade ago, GSK was out of oncology. It could soon pick up approval for its sixth cancer drug.
STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer
A Phase 3 trial of a targeted drug developed by Merck and China’s Kelun-Biotech cut by one-third the risk of death in patients with advanced endometrial cancer.
STAT+: Rising premiums, a sad Medicaid gathering, and a new fraud crackdown
The cost of health insurance is surging, and CMS presses ahead with a new fraud crackdown.
STAT+: Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO
A targeted drug from Incyte, when used in combination with chemotherapy, induced lasting tumor responses in certain patients with pancreatic cancer.
STAT+: Five biotech updates to read after ESMO this weekend
Moderna and Merck are racing to submit their personalized cancer vaccine for FDA approval, expected in 2027, according to Moderna CEO Stéphane Bancel.
STAT+: Pharmalittle: We’re reading about a Roche lung cancer drug, a Bristol CAR-T trial death, and more
Bristol Myers Squibb reported that one patient died after receiving its investigational CAR-T therapy in an early autoimmune trial
A virus that afflicts cows makes the jump to a human
For the first time, a human has been infected with the Shamonda virus, according to French officials. The World Health Organization says broader transmission is unlikely.
The pet I’ll never forget: Clement was hit by a car and left to die in a ditch – then found his beautiful purpose
Before being rescued, he had an extremely traumatic experience. You’d never know it though, from the joy his patience and sunny nature bring to those who most need himIn December …
NHS consultants to go on two-day strike in England in November, says BMA
Industrial action by senior doctors to begin on 25 November, with only emergency cover provided, union saysSenior doctors in England plan to go on strike for two days in November,…
The 4 stages of women’s heart health: Experts present new framework
New guidance is intended to help girls and women — and their doctors — recognize four distinct phases in heart health.